Literature DB >> 2459905

Intraocular herpes simplex virus injection in neonatal rats induces sympathetic nerve cell destruction: effect of nerve growth factor.

L Aloe1.   

Abstract

The effect of herpes simplex virus (HSV) injection on the sympathetic nerve system of newborn rats was studied at structural, ultrastructural, and immunohistochemical levels. It was found that HSV injected into the anterior eye chamber is retrogradely transported and reaches the nerve cell bodies of the ipsilateral superior cervical ganglion (SCG) after 18-24 hr, causing complete cell destruction within 3-4 days. In subsequent days, nerve cells of the contralateral SCG, spinal sensory ganglia, chromaffin cells and brain cells also become infected and are eventually killed by the virus. Pretreatment with nerve growth factor (NGF) produces an initial protection from viral cell destruction, but does not block the final, lethal effect of the virus. These investigations demonstrate that sympathetic nerve cell destruction can be induced in newborn rodents by HSV, and that NGF treatment renders the cells, for a time-limited period, more resistant to the virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2459905     DOI: 10.1016/0736-5748(87)90011-6

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  3 in total

1.  Stress and reactivation of latent herpes simplex virus: a fusion of behavioral medicine and molecular biology.

Authors:  F J Jenkins; A Baum
Journal:  Ann Behav Med       Date:  1995

2.  Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV.

Authors:  E Garaci; M C Caroleo; L Aloe; S Aquaro; M Piacentini; N Costa; A Amendola; A Micera; R Caliò; C F Perno; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Topical treatment with nerve growth factor in an animal model of herpetic keratitis.

Authors:  Alessandro Lambiase; Marco Coassin; Nicola Costa; Paolo Lauretti; Alessandra Micera; Emiliano Ghinelli; Luigi Aloe; Paolo Rama; Stefano Bonini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-05-04       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.